Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Income Taxes

v3.19.1
Note 9 - Income Taxes
3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
NOTE
9
 — INCOME TAXES
 
Due to Milestone Scientific's history of operating losses, full valuation allowances have been provided for all of Milestone Scientific's deferred tax assets At
March 31, 2019 
and
December 31, 2018 ,
no
recognition was given to the utilization of the remaining net operating loss carry forwards in each of these periods.
 
The utilization of Milestone Scientific's net operating losses
may
be subject to a substantial limitation due to the "change of ownership provisions" under Section
382
of the Internal Revenue Code and similar state provisions. Such limitation
may
result in the expiration of the net operating loss carry forwards before their utilization. Milestone Scientific has established a
100%
valuation allowance for all its deferred tax assets due to uncertainty as to their future realization.